{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:29Z","timestamp":1760264789480},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["curr drug targets immune endocr metabol disord"],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.2174\/1568008054863772","type":"journal-article","created":{"date-parts":[[2005,8,30]],"date-time":"2005-08-30T18:52:29Z","timestamp":1125427949000},"page":"315-322","source":"Crossref","is-referenced-by-count":34,"title":["Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases"],"prefix":"10.2174","volume":"5","author":[{"given":"S.","family":"Miyake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets - Immune, Endocrine & Metabolic Disorders"],"original-title":[],"language":"en","deposited":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T02:26:01Z","timestamp":1313461561000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaselect.com\/rpsv\/cgi-bin\/cgi?ini=xref&body=linker&reqdoi=10.2174\/1568008054863772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["1568-0088(20050901)5:3L.315;1-"],"URL":"https:\/\/doi.org\/10.2174\/1568008054863772","relation":{},"ISSN":["1568-0088","0000-0000"],"issn-type":[{"value":"1568-0088","type":"print"},{"value":"0000-0000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}